Keep it real
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Uscf is the lead, not Oncs
So no problem on ONCS side
Advfn
Interesting. What is your take on mAbs and dna vaccines? I am an INO-fan
Do you have any proof for that?
Well show us the IND and we will take it from there
There we go again.
Its rather to give you facts to prove that something did not happen.
How about you come up with the IND filing
sorry Popey, I cannot help you on this one
Nobody said that Oncosec has applied for the IND, so speculating that, because it was not granted within 30d, and therefore it must be on a clinical hold, is not truthful.
cheers Ash, but I comeback to the close to commercial by years end.
I still do not understand how he can make that statement as he still needs to start a P2, get a P3,... timewise this cannot be accomplished in 6 months?
Again go read the pr
No idea where you got that impression. Sure people on here were thinking and dreaming it but nothing in the pr says or alludes to a partnership with Merck
Then again, it could happen in the future
Go back and read the pr, such thing is not in there. The pr mentioned a collaboration with USCF and Merck delivering Keytruda
thx Ash but that does not explain how they can be close to a commercial product by year's end.
P2 still has to start. Unless they can get breakthrough status and skip P3, but that would be a bit presumptuous by Glynn to presume.
Why would it flush out retail longs? An RS would bring us to Nasdaq with added exposure.
Don't worry about that. One day the science will kick in.
One thing puzzles: commercial product by year end. How are they gonna do that? only P1 so far and P2 has not started yet.
Yeah me :)
you mean from only 1 patient?
That is all fine with me Lasers. But then why could Punit not come out and say as such: sorry guys but the FDA is not delivering on time.
I like your viewpoint Wait, and I do consider myself being long. That is why I only halve my position.
However, what I do not like is that we get no explanation as why twice ONCS missed their own stated timeline. At the bare minimum they have to give us an explanation.
Thanks for your analysis Tom, always appreciated
Jbem, each to his own opinion.
As for myself, I have halved my position in Oncosec due to missing twice the start of the p2b without an explanation.
I don't mind the missing, I can understand you cannot control everything, especially when USCF is in the lead. However, I do not like being kept in the dark.
As for the science, I will continue to follow it 'cause I do believe they have the goods to increase the PD1 responders. Time will tell.
Ofcourse it does, but I do not take it personal. Nor do I believe it is intentional deceit
Must be good if they will present it
Everybody seems to ignore the toxicity, cytokine storm and outside-of-body production that goes with car-t
Tapimmune is far superior but still unrecognized
I am ready to catch with orders at .75 and .65
Tom you make it sound like the sheeple have no mind of their own. Each individual can see the trading going on and react according their own plan.
Both the ascent and descent were too big. I am awaiting further developments as these will propel us further
Jbem, you seem to take it very personal. The way you phrase is, you make it sound like Punit has intentionally lied to the public. That makes it fraud. I would not go so far.
Sure we are all frustrated that the P2b is still not rolling. But, all that does not mean that there is something wrong with the science fundamentals.
I wouldn't mind, then I can fill another order. But we shouldn't finish here!
Yeah it's nice to come here and take refuge from the carnage going on outside our doors.
Compare Anavex to TapImmune...
Anyone here who think the sell-off is not related to the general market mood due Greece?
Or have investors finally realized whar ONCS is worth?
Just in case anyone is doubting, Greece is the cause in my opinion.
Yeah i know... Should I smile or cry? It's a smile, but only a small one ;)
Put in some more at .75 and .65, one never knows
It's important that we should end the day above .7 and preferably above 1 or the warrants clock get reset'
Trickle down effects are here. My orders at 1.05 and 0.95 were filled. Lets see if 0.85 gets filled...
Ofcourse this is not a nice thing to watch, but still a great opportunity to buy
did you buy on Thursday or were you prewarned?
the rally started on Thursday Moneypenny. you can call Friday hardly a confirmation of a move.
Lets wait and see how this pans out a week from here when the dust has settled of those buying in.
Then the waiting begins for SNGX to deliver on milestones and propel us further.
no need to pump, unless you want to explain in some more detail the beauty of this chart?
Wrong spellinc, should be CAC40, Paris
Sound very good arguments!
Nevertheless I'll put in a sting order, just in case everybody loses their minds (DAX and QAQ are down -4%)
Anybody expecting the Greece-debacle trickling down to TPIV?